CLSD
Price
$0.34
Change
-$0.01 (-2.86%)
Updated
Sep 8, 04:57 PM (EDT)
Capitalization
27.16M
71 days until earnings call
IMNN
Price
$5.81
Change
+$0.05 (+0.87%)
Updated
Sep 8, 04:57 PM (EDT)
Capitalization
14.51M
70 days until earnings call
Interact to see
Advertisement

CLSD vs IMNN

Header iconCLSD vs IMNN Comparison
Open Charts CLSD vs IMNNBanner chart's image
Clearside Biomedical
Price$0.34
Change-$0.01 (-2.86%)
Volume$2.45K
Capitalization27.16M
Imunon
Price$5.81
Change+$0.05 (+0.87%)
Volume$400
Capitalization14.51M
CLSD vs IMNN Comparison Chart in %
Loading...
CLSD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLSD vs. IMNN commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLSD is a Hold and IMNN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (CLSD: $0.35 vs. IMNN: $5.76)
Brand notoriety: CLSD and IMNN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLSD: 8% vs. IMNN: 14%
Market capitalization -- CLSD: $27.16M vs. IMNN: $14.51M
CLSD [@Biotechnology] is valued at $27.16M. IMNN’s [@Biotechnology] market capitalization is $14.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLSD’s FA Score shows that 0 FA rating(s) are green whileIMNN’s FA Score has 0 green FA rating(s).

  • CLSD’s FA Score: 0 green, 5 red.
  • IMNN’s FA Score: 0 green, 5 red.
According to our system of comparison, IMNN is a better buy in the long-term than CLSD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLSD’s TA Score shows that 5 TA indicator(s) are bullish while IMNN’s TA Score has 3 bullish TA indicator(s).

  • CLSD’s TA Score: 5 bullish, 3 bearish.
  • IMNN’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CLSD is a better buy in the short-term than IMNN.

Price Growth

CLSD (@Biotechnology) experienced а -5.85% price change this week, while IMNN (@Biotechnology) price change was -2.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.99%. For the same industry, the average monthly price growth was +10.86%, and the average quarterly price growth was +33.07%.

Reported Earning Dates

CLSD is expected to report earnings on Nov 18, 2025.

IMNN is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+1.99% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLSD($27.2M) has a higher market cap than IMNN($14.5M). IMNN YTD gains are higher at: -53.556 vs. CLSD (-63.579). IMNN has higher annual earnings (EBITDA): -14.79M vs. CLSD (-16.2M). CLSD has more cash in the bank: 9.38M vs. IMNN (4.73M). CLSD has less debt than IMNN: CLSD (533K) vs IMNN (1.19M). CLSD has higher revenues than IMNN: CLSD (4.17M) vs IMNN (0).
CLSDIMNNCLSD / IMNN
Capitalization27.2M14.5M188%
EBITDA-16.2M-14.79M110%
Gain YTD-63.579-53.556119%
P/E RatioN/AN/A-
Revenue4.17M0-
Total Cash9.38M4.73M198%
Total Debt533K1.19M45%
FUNDAMENTALS RATINGS
CLSD vs IMNN: Fundamental Ratings
CLSD
IMNN
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9595
P/E GROWTH RATING
1..100
79100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMNN's Valuation (57) in the Medical Specialties industry is in the same range as CLSD (89) in the Pharmaceuticals Major industry. This means that IMNN’s stock grew similarly to CLSD’s over the last 12 months.

IMNN's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as CLSD (100) in the Pharmaceuticals Major industry. This means that IMNN’s stock grew similarly to CLSD’s over the last 12 months.

IMNN's SMR Rating (100) in the Medical Specialties industry is in the same range as CLSD (100) in the Pharmaceuticals Major industry. This means that IMNN’s stock grew similarly to CLSD’s over the last 12 months.

IMNN's Price Growth Rating (95) in the Medical Specialties industry is in the same range as CLSD (95) in the Pharmaceuticals Major industry. This means that IMNN’s stock grew similarly to CLSD’s over the last 12 months.

CLSD's P/E Growth Rating (79) in the Pharmaceuticals Major industry is in the same range as IMNN (100) in the Medical Specialties industry. This means that CLSD’s stock grew similarly to IMNN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLSDIMNN
RSI
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
78%
Momentum
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
79%
N/A
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
89%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 19 days ago
74%
Declines
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
80%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
CLSD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHM140.572.96
+2.15%
Pultegroup
VTEX4.090.07
+1.74%
VTEX
NCNO30.40-0.05
-0.16%
nCino
EFOI2.44-0.07
-2.97%
Energy Focus
BSGM4.41-0.16
-3.50%
BioSig Technologies, Inc.

CLSD and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLSD has been loosely correlated with ABVX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CLSD jumps, then ABVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLSD
1D Price
Change %
CLSD100%
-1.23%
ABVX - CLSD
51%
Loosely correlated
+2.90%
ANEB - CLSD
31%
Poorly correlated
-0.42%
BOLT - CLSD
31%
Poorly correlated
+7.23%
IMNN - CLSD
30%
Poorly correlated
+0.61%
ACLX - CLSD
28%
Poorly correlated
+0.64%
More

IMNN and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNN has been loosely correlated with REPL. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNN jumps, then REPL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNN
1D Price
Change %
IMNN100%
+0.61%
REPL - IMNN
61%
Loosely correlated
+8.95%
ABVX - IMNN
57%
Loosely correlated
+2.90%
SPRO - IMNN
41%
Loosely correlated
+0.47%
MRUS - IMNN
36%
Loosely correlated
+1.87%
CLSD - IMNN
30%
Poorly correlated
-1.23%
More